Literature DB >> 23629596

Thermal pain and sensory processing in children with sickle cell disease.

James D O'Leary1, Mark W Crawford, Isaac Odame, George D Shorten, Patricia A McGrath.   

Abstract

OBJECTIVES: Early tissue injury and recurrent pain in sickle cell disease (SCD) may alter pain and sensory processing. In this study, we evaluate thermal pain and sensory processing for 27 children aged 10.3 to 18.3 years with SCD and 28 African-American control patients.
MATERIALS AND METHODS: Outcome measures included heat and cold detection thresholds, heat and cold pain thresholds, and thermal perceptual sensitization at the volar surface of the dominant forearm and thenar eminence of the nondominant hand.
RESULTS: Children with SCD were less sensitive to heat detection (P=0.006) and cold detection (P=0.015) stimuli at the thenar eminence compared with controls. At the forearm, no difference was found between groups for cold (P=0.58) or heat (P=0.07) detection thresholds. Children with SCD had increased sensitivity to cold pain at the forearm (P=0.03) compared with controls, but not when measured at the thenar eminence (P=0.084). There was no evidence that children with SCD had altered heat pain thresholds compared with controls. There was no difference between groups for perceptual sensitization at the thenar eminence (41% vs. 39%) (χ=0.15, P>0.1) or at the forearm (30% vs. 36%) (χ=0.23, P>0.5). DISCUSSION: Three of ten quantitative sensory tests were found to differ between groups. These results suggest that SCD may influence pain and sensory processing in children, but our interpretation is necessarily cautious. Due to the small differences in measures found between groups, further investigation is required to confirm our findings. If confirmed, the development of population-specific reference standards for quantitative sensory testing may emerge as a useful clinical tool for pain physicians in identifying and quantifying pain and sensory processing in children with SCD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23629596     DOI: 10.1097/AJP.0b013e318292a38e

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  25 in total

1.  Youth and Parent Appraisals of Participation in a Study of Spontaneous and Induced Pediatric Clinical Pain.

Authors:  Kara Hawley; Jeannie S Huang; Matthew Goodwin; Damaris Diaz; Virginia R de Sa; Kathryn A Birnie; Christine T Chambers; Kenneth D Craig
Journal:  Ethics Behav       Date:  2018-04-30

2.  A QST-based Pain Phenotype in Adults With Sickle Cell Disease: Sensitivity and Specificity of Quality Descriptors.

Authors:  Brenda W Dyal; Miriam O Ezenwa; Saunjoo L Yoon; Roger B Fillingim; Yingwei Yao; Judith M Schlaeger; Marie L Suarez; Zaijie J Wang; Robert E Molokie; Diana J Wilkie
Journal:  Pain Pract       Date:  2019-10-18       Impact factor: 3.183

3.  Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.

Authors:  Maha Khaleel; Mammen Puliyel; Payal Shah; John Sunwoo; Roberta M Kato; Patjanaporn Chalacheva; Wanwara Thuptimdang; Jon Detterich; John C Wood; Jennie Tsao; Lonnie Zeltzer; Richard Sposto; Michael C K Khoo; Thomas D Coates
Journal:  Am J Hematol       Date:  2017-08-17       Impact factor: 10.047

Review 4.  Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature.

Authors:  Amanda M Brandow; Rebecca A Farley; Julie A Panepinto
Journal:  Pediatr Blood Cancer       Date:  2015-05-13       Impact factor: 3.167

5.  Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain?

Authors:  Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Yingwei Yao; Marie L Suarez; Cherese Pullum; Judith M Schlaeger; Roger B Fillingim; Diana J Wilkie
Journal:  Pain Pract       Date:  2015-01-12       Impact factor: 3.183

6.  Relationship of Pain Quality Descriptors and Quantitative Sensory Testing: Sickle Cell Disease.

Authors:  Brenda W Dyal; Miriam O Ezenwa; Saunjoo L Yoon; Roger B Fillingim; Yingwei Yao; Judith M Schlaeger; Marie L Suarez; Zaijie J Wang; Robert E Molokie; Diana J Wilkie
Journal:  Nurs Res       Date:  2019 Sep/Oct       Impact factor: 2.381

Review 7.  Pain-measurement tools in sickle cell disease: where are we now?

Authors:  Deepika S Darbari; Amanda M Brandow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

8.  Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use.

Authors:  Amanda M Brandow; Nancy J Wandersee; Mahua Dasgupta; Raymond G Hoffmann; Cheryl A Hillery; Cheryl L Stucky; Julie A Panepinto
Journal:  Br J Haematol       Date:  2016-08-19       Impact factor: 6.998

9.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

10.  Sensitivities to Thermal and Mechanical Stimuli: Adults With Sickle Cell Disease Compared to Healthy, Pain-Free African American Controls.

Authors:  Robert E Molokie; Zaijie J Wang; Yingwei Yao; Keesha L Powell-Roach; Judith M Schlaeger; Marie L Suarez; David A Shuey; Veronica Angulo; Jesus Carrasco; Miriam O Ezenwa; Roger B Fillingim; Diana J Wilkie
Journal:  J Pain       Date:  2019-11-13       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.